Walleye Capital’s Medifast MED Stock Holding History

Walleye Capital’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,100	Closed	-$138K	–	4906
2025 Q3	$138K	Buy	10,100 +10,000	+10,000%	+$140K	﹤0.01%	3543
2025 Q2	$1.41K	Sell	100 -17,800	-99%	-$234K	﹤0.01%	4398
2025 Q1	$241K	Buy	+17,900	New	+$269K	﹤0.01%	3119
2024 Q4	–	Sell	-6,100	Closed	-$117K	–	5260
2024 Q3	$117K	Sell	6,100 -7,400	-55%	-$143K	﹤0.01%	4329
2024 Q2	$295K	Buy	13,500 +1,900	+16%	+$50.6K	﹤0.01%	3991
2024 Q1	$445K	Buy	+11,600	New	+$562K	﹤0.01%	3301
2023 Q4	–	Sell	-3,400	Closed	-$254K	–	5288
2023 Q3	$254K	Sell	3,400 -5,400	-61%	-$479K	﹤0.01%	3366
2023 Q2	$811K	Buy	8,800 +6,500	+283%	+$579K	﹤0.01%	2026
2023 Q1	$238K	Buy	2,300 +1,900	+475%	+$211K	﹤0.01%	2329
2022 Q4	$46.1K	Buy	+400	New	+$46.6K	﹤0.01%	2538
2019 Q3	–	Sell	-1,200	Closed	-$154K	–	2109
2019 Q2	$154K	Sell	1,200 -2,000	-63%	-$278K	0.02%	1070
2019 Q1	$408K	Buy	+3,200	New	+$406K	0.07%	464

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SCP

Steamboat Capital Partners Rye, New York $403M AUM 43.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Walleye Capital's MED Position: Q1 2026 in Review

Walleye Capital opened a new position in Medifast (MED) in Q1 2026: 1 share worth $10. The stake represents ﹤0.01% of the portfolio and ranks #4312 among its holdings. This is a return to the name: Walleye Capital previously reported a position in MED as recently as Q3 2025.

Walleye Capital first reported a position in MED in Q2 2019 and has held it in 14 quarters since. The position peaked at $2.2M in Q3 2022. 111 funds tracked by Wall St. Rank hold MED as of Q1 2026.

Walleye Capital held 1 share of Medifast worth $10 as of Q1 2026.
Medifast was a new Walleye Capital position in Q1 2026.
Medifast made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #4312 holding.
Walleye Capital first reported a position in Medifast in Q2 2019 and has held it in 14 quarters since.
Walleye Capital's Medifast position peaked at $2.2M in Q3 2022.
111 funds tracked by Wall St. Rank held Medifast as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.